385 filings
8-K
ALKS
Alkermes plc
31 May 24
Departure of Directors or Certain Officers
4:05pm
DEFA14A
ALKS
Alkermes plc
14 May 24
Additional proxy soliciting materials
4:30pm
10-Q
2024 Q1
ALKS
Alkermes plc
Quarterly report
1 May 24
5:14pm
8-K
ALKS
Alkermes plc
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
ARS
2023 FY
ALKS
Alkermes plc
15 Apr 24
Annual report to shareholders
4:27pm
DEFA14A
5y97unr3
15 Apr 24
Additional proxy soliciting materials
4:23pm
8-K
xhf9ztygejh
9 Apr 24
Regulation FD Disclosure
7:09am
8-K
2xp1bjk4pwacy
7 Mar 24
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7:09am
8-K
lnu0sx3g k9ru9yk3l
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
5sjz3bs763yl95gb9
5 Feb 24
Departure of Directors or Certain Officers
4:29pm
8-K
q3qu8e9js2
8 Jan 24
Regulation FD Disclosure
7:00am
8-K
62cx 6fkh6
14 Dec 23
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
6:13am
8-K
t5zng07
8 Dec 23
Departure of Directors or Certain Officers
4:05pm
8-K
z7vjebpsdfemm3
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
o23t0rk2bolf 28
31 Oct 23
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
5:18pm
8-K
0kawj gjz6b64
27 Oct 23
Other Events
5:12pm